Voyager Therapeutics, Inc.

VYGR Net buying

CIK 0001640266 #3912 in the set updated 17 Sep 2026

Bought (120 mo)

$91.90M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$24.96M

$316.75K on a plan · $1.64M straight out of an exercise

Sold at will

$23.00M

99 of 116 sales

Net

+$66.94M

+$68.90M against sales at will

By person

24 insiders · 123 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

NEUROCRINE BIOSCIENCES INC entity

10% owner

$89.03M (2)

—

+$89.03M

8,575,316

13.92%

$33.19M

—

Third Rock Ventures III, L.P. entity

10% owner

—

$12.72M (13)

−$12.72M

3,185,291

5.17%

$12.33M

−71.2%

EcoR1 Capital, LLC entity

10% owner

$2.66M (2)

$7.14M (3)

−$4.48M

3,851,507

6.25%

$14.91M

−9.9%

Henderson Jane

Sr. V.P. & CFO, Corp. Dev.

—

$1.03M (4) scheduled

−$1.03M

0

0.0000%

$0.00

—

Ravina Bernard

Chief Medical Officer

—

$848.62K (10)

−$848.62K

0

0.0000%

$0.00

−100.0%

Sandrock Alfred

President and CEO

—

$620.38K (10)

−$620.38K

472,549

0.7669%

$1.83M

+3,607%

Sah Dinah Ph.D.

Chief Scientific Officer

—

$468.69K (1) scheduled

−$468.69K

163,688

0.2656%

$633.47K

−3.7%

Swartz Robin

COO & CBO

—

$451.36K (18)

−$451.36K

199,738

0.3242%

$772.99K

+206.8%

Carter Todd Alfred

Chief Scientific Officer

—

$367.89K (18) scheduled

−$367.89K

145,718

0.2365%

$563.93K

+302.6%

Turenne Andre

President & CEO

—

$293.26K (3)

−$293.26K

322,375

0.5232%

$1.25M

—

Hesslein Robert W.

Senior VP & General Counsel

—

$258.55K (13)

−$258.55K

102,200

0.1659%

$395.51K

—

PFREUNDSCHUH PETER P.

Chief Financial Officer

—

$122.91K (2)

−$122.91K

175,669

0.2851%

$679.84K

—

GERAGHTY JAMES A

Director

$113.10K (2)

—

+$113.10K

76,588

0.1243%

$296.40K

+8.5%

Ferguson Toby

Chief Medical Officer

—

$105.46K (2)

−$105.46K

183,914

0.2985%

$711.75K

—

Higgins Michael J

Director

—

$93.07K (1)

−$93.07K

31,314

0.0508%

$121.19K

—

Dorval Allison

Chief Financial Officer

—

$91.20K (3)

−$91.20K

109,894

0.1783%

$425.29K

+4,047%

Khwaja Omar

See remarks

—

$85.77K (3)

−$85.77K

120,509

0.1956%

$466.37K

—

Fahey Sandell Jacquelyn

Chief Legal Officer

—

$54.31K (2)

−$54.31K

123,143

0.1998%

$476.56K

—

Jorgensen Nathan D.

Chief Financial Officer

—

$54.24K (2) scheduled

−$54.24K

151,416

0.2457%

$585.98K

—

Ottmer Matthew P.

Chief Operating Officer

—

$49.75K (1)

−$49.75K

26,276

0.0426%

$101.69K

—

Burek Julie

VP, Finance

—

$35.47K (6)

−$35.47K

52,458

0.0851%

$203.01K

+58.9%

PIERCE GLENN

Director

$92.20K (1)

$63.73K (1)

+$28.47K

21,788

0.0354%

$84.32K

—

LEVIN MARK J

Director

—

—

—

6,427,874

10.43%

$24.88M

−42.1%

Shiferman Gregory L.

SVP and General Counsel

—

—

—

50,000

0.0811%

$193.50K

—

Individual transactions

0

Nothing of that kind in this period.

What was left out

Form 4 filings counted 260

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 12

Sales on a Rule 10b5-1 plan 10

Sales straight out of an exercise 7

Sales at will 99

Transactions with no price 0

Shares from compensation/vesting 13,498,370

Sales filed before the plan box existed 67

History held since 21 Dec 2016